Comprehensive laboratory support for all phases of clinical trials
In this webinar, presenters discuss aspects of an adoptive cell therapy preclinical program that are central to an IND/IMPD submission - namely, in vitro and in vivo pharmacology, toxicology and pharmacokinetics (PK) assessments using the appropriate models & test systems.即刻观看
The development of a new biologic requires effective management of time and risk. The drug manufacturing process will progress in scale and likely location for both drug substance and drug product.阅读更多
In this on-demand webinar, learn more about the key considerations and best practices for supporting your global clinical trial with regulated bioanalysis in China. Topics covered include: special requirements for China submission studies, differences in global quality standards and technical expertise, resourcing and customs challenges in China, and advanced technologies for supporting existing and emerging modalities.阅读更多
Developing a vaccine or therapeutic in response to the outbreak of the 2019 Novel Coronavirus (COVID-19) requires a laboratory with significant technical and cross-functional experience. Covance Central Laboratories is prepared to support your COVID-19 studies.阅读更多
PhD-level leaders within the Covance Biomarker Solution Center can provide specialized therapeutic area expertise to create a successful biomarker strategy for your next study.